{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:56:53Z","timestamp":1786964213607,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670168"],"award-info":[{"award-number":["81670168"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470342"],"award-info":[{"award-number":["81470342"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370666"],"award-info":[{"award-number":["81370666"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270644"],"award-info":[{"award-number":["81270644"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81621001"],"award-info":[{"award-number":["81621001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bbmt.2018.11.020","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T02:20:33Z","timestamp":1543026033000},"page":"529-537","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Effects of Low-Dose Glucocorticoid Prophylaxis on Chronic Graft-versus-Host Disease and Graft-versus-Host Disease\u2013Free, Relapse-Free Survival after Haploidentical Transplantation: Long-Term Follow-Up of a Controlled, Randomized Open-Label Trial"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6124-6050","authenticated-orcid":false,"given":"Ying-Jun","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Ping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Rong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Qian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Han","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei-Fei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2145-6643","authenticated-orcid":false,"given":"Xiao-Jun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2018.11.020_bib0001","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0002","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa1203517","article-title":"Peripheral-blood stem cells versus bone marrow from unrelated donors","volume":"367","author":"Anasetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0003","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1182\/blood-2014-10-609032","article-title":"Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation","volume":"125","author":"Holtan","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0004","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1002\/cncr.30540","article-title":"Optimal dose of rabbit thymoglobulin in conditioning regimens for unmanipulated, haploidentical, hematopoietic stem cell transplantation: Long-term outcomes of a prospective randomized trial","volume":"123","author":"Chang","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0005","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1056\/NEJMra1703472","article-title":"Pathophysiology of chronic graft-versus-host disease and therapeutic targets","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0006","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMra1609337","article-title":"Acute graft-versus-host disease\u2014biologic process, prevention, and therapy","volume":"377","author":"Zeiser","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0007","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1182\/blood.V89.10.3880","article-title":"Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial","volume":"89","author":"Deeg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0008","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1182\/blood.V96.3.1194a","article-title":"Cyclosporine (CSP) or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized trial","volume":"96","author":"Deeg","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0009","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood.V96.7.2391","article-title":"Cyclosporine, methotrexate, and methylprednisolone compared with cyclosporine and methotrexate for the prevention of graft-versus-host disease in bone marrow transplantation from HLA-identical sibling donor: a prospective randomized study","volume":"96","author":"Ruutu","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0010","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1038\/leu.2008.105","article-title":"Corticosteroids in the prevention of graft-vs-host disease after allogeneic myeloablative stem cell transplantation: a systematic review and meta-analysis","volume":"22","author":"Quellmann","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0011","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1182\/blood.V76.5.1037.1037","article-title":"What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?","volume":"76","author":"Storb","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0012","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0013","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.bbmt.2016.02.020","article-title":"Association of cumulative steroid dose with risk of infection after treatment for severe acute graft-versus-host disease","volume":"22","author":"Matsumura-Kimoto","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0014","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3899\/jrheum.170418","article-title":"Association between glucocorticoid exposure and healthcare expenditures for potential glucocorticoid-related adverse events in patients with rheumatoid arthritis","volume":"45","author":"Best","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0015","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1200\/JCO.2015.63.8817","article-title":"Controlled, randomized, open-label trial of risk-stratified corticosteroid prevention of acute graft-versus-host disease after haploidentical transplantation","volume":"34","author":"Chang","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0016","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1200\/JCO.2015.66.0902","article-title":"Graft-versus-host disease prevention: corticosteroids revisited","volume":"34","author":"Alyea","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0017","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1182\/blood.V84.4.1328.1328","article-title":"Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention","volume":"84","author":"Sayer","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1083-8791(99)70003-0","article-title":"Cyclosporine, methotrexate, and prednisone compared with cyclosporine and prednisone for prevention of acute graft-vs.-host disease: effect on chronic graft-vs.-host disease and long-term survival","volume":"5","author":"Ross","year":"1999","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0019","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/cncr.31100","article-title":"A randomized study of cyclosporine and methotrexate with or without methylprednisolone for the prevention of graft-versus-host disease: Improved long-term survival with triple prophylaxis","volume":"124","author":"Ruutu","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0020","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.bbmt.2018.01.002","article-title":"Blood and Marrow Transplant Clinical Trials Network report on the development of novel endpoints and selection of promising approaches for graft-versus-host disease prevention trials","volume":"24","author":"Pasquini","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0021","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.bmt.1705445","article-title":"Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies","volume":"38","author":"Huang","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0022","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/bmt.2013.191","article-title":"Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial","volume":"49","author":"Wang","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0023","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1182\/blood-2014-03-563130","article-title":"Who is the best donor for a related HLA haplotype-mismatched transplant?","volume":"124","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0024","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/bmt.2008.267","article-title":"The impact of graft composition on clinical outcomes in unmanipulated HLA-mismatched\/haploidentical hematopoietic SCT","volume":"43","author":"Luo","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0025","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/bmt.2009.73","article-title":"Association of natural killer cells in allografts with transplant outcomes in patients receiving G-CSF-mobilized PBSC grafts and G-CSF-primed BM grafts from HLA-haploidentical donors","volume":"44","author":"Zhao","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0026","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3324\/haematol.10570","article-title":"Donor lymphocyte infusion for the treatment of leukemia relapse after HLA-mismatched\/haploidentical T-cell-replete hematopoietic stem cell transplantation","volume":"92","author":"Huang","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0027","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease. I. Diagnosis and Staging Working Group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0028","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s10875-011-9630-7","article-title":"Immune reconstitution following unmanipulated HLA-mismatched\/haploidentical transplantation compared with HLA-identical sibling transplantation","volume":"32","author":"Chang","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0029","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1046\/j.1365-2141.1997.1112925.x","article-title":"IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade","volume":"97","author":"Rowlings","year":"1997","journal-title":"Br J Haematol"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0030","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1182\/blood-2015-11-680876","article-title":"Corruption of dendritic cell antigen presentation during acute GVHD leads to regulatory T-cell failure and chronic GVHD","volume":"128","author":"Leveque-El Mouttie","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0031","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/sj.bmt.1705313","article-title":"Risk-factor analysis for predicting progressive- or quiescent-type chronic graft-versus-host disease in a patient cohort with a history of acute graft-versus-host disease after allogeneic stem cell transplantation","volume":"37","author":"Sohn","year":"2006","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0032","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1172\/JCI90593","article-title":"Cytokine mediators of chronic graft-versus-host disease","volume":"127","author":"MacDonald","year":"2017","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.bbmt.2018.11.020_bib0033","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH consensus development project on criteria for clinical trials in chronic graft-versus-host disease. II. The 2014 Pathology Working Group report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0034","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0035","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jaci.2016.12.992","article-title":"Viral reactivations and associated outcomes in the context of immune reconstitution after pediatric hematopoietic cell transplantation","volume":"140","author":"Admiraal","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0036","doi-asserted-by":"crossref","first-page":"3380","DOI":"10.1182\/blood.V97.11.3380","article-title":"Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation","volume":"97","author":"Storek","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0037","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1182\/blood-2004-01-0348","article-title":"De novo generation of CD4 T cells against viruses present in the host during immune reconstitution","volume":"105","author":"Kalina","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0038","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1432-2277.2011.01264.x","article-title":"Metabolic bone diseases in patients after allogeneic hematopoietic stem cell transplantation: report from the consensus conference on clinical practice in chronic graft-versus-host disease","volume":"24","author":"Hautmann","year":"2011","journal-title":"Transpl Int"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0039","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1200\/JCO.2014.57.8195","article-title":"Increased incidence of fractures in recipients of hematopoietic stem-cell transplantation","volume":"33","author":"Pundole","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0040","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bbmt.2013.12.567","article-title":"Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents","volume":"20","author":"Li","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0041","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.bbmt.2010.03.008","article-title":"Corticosteroid dose as a risk factor for avascular necrosis of the bone after hematopoietic cell transplantation","volume":"16","author":"McAvoy","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2018.11.020_bib0042","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.bbmt.2017.06.011","article-title":"Quality of life after allogeneic hematopoietic cell transplantation according to affected organ and severity of chronic graft-versus-host disease","volume":"23","author":"Kurosawa","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118307535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879118307535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:07:05Z","timestamp":1761059225000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879118307535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S1083879118307535"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.11.020","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Low-Dose Glucocorticoid Prophylaxis on Chronic Graft-versus-Host Disease and Graft-versus-Host Disease\u2013Free, Relapse-Free Survival after Haploidentical Transplantation: Long-Term Follow-Up of a Controlled, Randomized Open-Label Trial","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2018.11.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 American Society for Blood and Marrow Transplantation.","name":"copyright","label":"Copyright"}]}}